Skip to main content

Table 1 Clinical characteristics of the study patients with PHSC and PHS

From: Clinical and imaging characteristics of primary hepatic sarcomatoid carcinoma and sarcoma: a comparative study

Variable

PHSC (n = 23)

PHS (n = 16)

P value

Age (y)a

54.0 ± 9.9

54.4 ± 13.4

0.276

Male: female ratio

20:3

11:5

0.235

Liver hepatitis cirrhosis

14 (73.7)

10 (62.5)

0.716

Clinical manifestations

11 (52.4)

11 (73.3)

0.500

Tumor markers

 AFP

9 (47.4)

5 (33.0)

0.495

 Ca19–9

5 (35.7)

2 (14.3)

0.385

 CEA

1 (6.7)

0

0.999

 Vascular invasion

13 (56.5)

4 (25.0)

0.099

 Intrahepatic metastasis

9 (40.9)

4 (25.0)

0.490

 Extrahepatic metastasis

12 (57.1)

6 (37.5)

0.325

  1. Note. Unless otherwise specified, data are numbers of patients, with percentages in parentheses, AFP A-fetoprotein, CA 19–9 Carbohydrate antigen 19–9, CEA Carcinoembryonic antigen
  2. aData are medians, with ranges in parentheses